RaySearch Laboratories AB ser. B (0GRZ)

65.10
+1.10(+1.72%)
  • Volume:
    1,717
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    65.10 - 65.10

0GRZ Overview

Prev. Close
64
Day's Range
65.1-65.1
Revenue
-
Open
62.95
52 wk Range
40.8-94.8
EPS
-
Volume
1,717
Market Cap
2.24B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
2,276
P/E Ratio
-
Beta
-
1-Year Change
-24.44%
Shares Outstanding
34,282,773
Next Earnings Date
24 Aug 2022
What is your sentiment on RaySearch Labs B?
or
Market is currently closed. Voting is open during market hours.

RaySearch Laboratories AB ser. B Company Profile

RaySearch Laboratories AB ser. B Company Profile

Employees
428
Market
Sweden

RaySearch Laboratories publ AB is a Sweden-based medical technology company that develops software for radiation therapy of cancer. It markets and sells its products mainly in the United States and in Europe through license agreements with medical technology companies and scientific institutions. As of December 31, 2011, 15 of the Company’s products were launched, including the software platform ORBIT (optimization of radiation therapy beams by iterative technique), which is available in its main products, and is a non-clinical system which functions as a research and development environment. Additionally, its solutions include software for optimizing Intensity Modulated Radiation Therapy (IMRT) plans for photons, adaptive technology for IMRT treatments and software for proton treatments. The Company’s commercial partners are Philips, Nucletron and IBA Dosimetry, among others. In April 2014, it established a German subsidiary, RaySearch Germany GmbH.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyBuyStrong BuyBuySell
Technical IndicatorsSellSellSellStrong BuyStrong Sell
SummaryNeutralNeutralNeutralStrong BuyStrong Sell